Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Featured

Blog

Protecting Innovation in an AI-Powered Age: Patents

Blog

How to Assess a Startup’s IP

Article

Analyzing SEPs: Strategies to Avoid or Prepare for Litigation

Blog

Hatch-Waxman 201

Article

Cross-Border Lessons in Using the Hague Evidence Convention

Authored by: Chris Marchese, Jeffrey Mok, Mohammad Reza Kameli

Blog | May 23, 2025

En Banc Federal Circuit Grants Google a New Trial in EcoFactor Case

Blog | May 23, 2025

John Squires Faces the Senate Judiciary Committee

Blog | May 23, 2025

HHS Sets Most-Favored-Nation Price Targets for Pharmaceuticals

Blog | May 19, 2025

Acting USPTO Director Stewart Issues First Decisions Under Interim Discretionary Denial Process

Blog | May 15, 2025

No Space at the Trademark Office for US SPACE FORCE

Blog | May 14, 2025

How Trump’s Latest Drug Price EO Could Impact Pharma

Article | May 14, 2025

Taking a Good Deposition, Part III: Conversations, Exhibits, Whether to Hold Your Fire at Deposition, and Dealing with Obstreperous Counsel

Article | May 09, 2025

Patent Diligence for VCs and PEs

Blog | May 09, 2025

ITC Round-Up: Q1 2025

Blog | May 07, 2025

Federal Circuit Clarifies Limits of Patent Eligibility for Machine Learning Claims

Blog | May 01, 2025

More Is More: Ensure Your Mark Is Protectable Before You Enforce

Blog | April 28, 2025

Can Clinical Trials Negate Patentability for Pharma Inventions?